Loading viewer...
earnings
Format: PDF earnings
Teva Pharmaceutical Industries' financial results presentation for the fourth quarter and full year 2022, delivered February 8, 2023. The presentation includes discussion of the company's generic pharmaceuticals portfolio, branded products including AUSTEDO, AJOVY, and COPAXONE, along with risk factors and forward-looking guidance.
earnings
37 Pages
earnings
25 Pages
Roche